Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants
February 08, 2021 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling...
Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treatment of Cancer Cachexia
February 02, 2021 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) today embarks on a collaboration with researchers from Trinity College Dublin to investigate pre-clinical...
Artelo Biosciences to Present at the LSX World Congress Virtual Conference
January 29, 2021 16:05 ET
|
Artelo Biosciences
LA JOLLA, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling...
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update
January 14, 2021 08:30 ET
|
Artelo Biosciences
Received Clinical Trial Authorization to Commence Cancer Appetite Recovery Phase I/II Clinical Study of ART27.13 in UK Awarded Mitacs Accelerate Grant LA JOLLA, Calif., Jan. 14, 2021 ...
Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
January 05, 2021 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid...
Artelo Biosciences Files Patent Application for New Formulation of ART27.13
December 09, 2020 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate...
Artelo Biosciences to Present at The 13th Annual LD Micro Main Event Conference on December 15th
December 08, 2020 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate...
Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors
December 02, 2020 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate...
Artelo Biosciences and University of Western Ontario Awarded Research Grant by Mitacs
November 23, 2020 08:30 ET
|
Artelo Biosciences
LA JOLLA, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate...
Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-Related Anorexia and Weight Loss
November 16, 2020 08:30 ET
|
Artelo Biosciences
First patients on track for enrollment this year Targeting multi-billion market with no approved therapies for cancer-related anorexia LA JOLLA, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) --...